Related Experiment Video
Updated: Aug 10, 2026
Murine Renal Transplantation Procedure
Published on: July 10, 2009
Cardiac assessment for renal transplantation
1Renal Medicine, Auckland City Hospital, Park Road, Grafton, Auckland 00001, New Zealand. hpilmore@adhb.govt.nz
Insights
Cardiac death is common in end-stage renal failure patients. Pre-transplant cardiac screening is advised for high-risk individuals, with myocardial perfusion studies offering a sensitive, less invasive option than angiography.
Area of Science:
- Nephrology
- Cardiology
- Transplantation Medicine
Background:
- Cardiac death is a significant concern for patients with end-stage renal failure (ESRF).
- Coronary artery disease (CAD) screening before renal transplantation is recommended for high-risk individuals.
- Optimal screening modalities and management strategies for CAD in this population remain undefined.
Purpose of the Study:
- To review the current literature on cardiac assessment and management of patients undergoing renal transplantation.
- To propose evidence-based algorithms for the cardiac evaluation and treatment of ESRF patients prior to renal transplantation.
Main Methods:
- Comprehensive literature review of studies concerning cardiac assessment and management in ESRF patients.
- Analysis of the sensitivity, invasiveness, and effectiveness of various screening tests for CAD, including exercise electrocardiography, myocardial perfusion studies, and coronary angiography.
- Evaluation of the risks and benefits associated with revascularization procedures in the renal failure population.
Main Results:
- Myocardial perfusion studies demonstrate higher sensitivity for CAD detection compared to exercise electrocardiography.
- Coronary angiography, while the gold standard, is more invasive.
- Revascularization for coronary artery stenoses carries high mortality and morbidity in ESRF patients, with limited evidence of benefit for asymptomatic lesions.
Conclusions:
- Myocardial perfusion studies represent a valuable, less invasive screening tool for CAD in high-risk ESRF patients awaiting transplantation.
- Prophylactic coronary intervention for asymptomatic CAD in ESRF patients is generally not recommended due to high procedural risks.
- Improved utilization of beta-blockers and aspirin in the renal population is warranted for cardiovascular risk management.
Abstract:
Cardiac death is common in patients with end-stage renal failure. Screening for coronary artery disease prior to renal transplantation is advisable in high-risk patients. The optimal screening test has not been defined; however, myocardial perfusion studies are more sensitive than exercise electrocardiography and are less invasive than coronary angiography, which remains the gold standard. The management of coronary artery disease prior to transplantation is contentious. Revascularization of coronary artery stenoses is associated with high mortality and morbidity in the renal failure population, and there is little data to indicate that most patients with asymptomatic coronary lesions will benefit from prophylactic coronary intervention. In addition, beta-blockers and aspirin are under-utilized in the renal population. This paper reviews the literature and proposes algorithms for the cardiac assessment and management of patients prior to renal transplantation.
Related Concept Videos
01:28Kidney Transplant I: Introduction
01:16Kidney Transplant III: Nursing Management
01:26Kidney Transplant II: Surgical Procedure
01:28Cardiac Catheterization I: Pre-Procedure Overview
01:26Cardiac Catheterization IV: Nursing Management
01:19Imaging Studies VII: Vascular Imaging